We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,939.00
Bid: 1,939.00
Ask: 1,941.00
Change: 14.00 (0.73%)
Spread: 2.00 (0.103%)
Open: 1,937.00
High: 1,945.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Ebola fears hit UK stocks after NY doctor tests positive for virus

Fri, 24th Oct 2014 08:35

UK stocks experienced some selling pressure on Friday morning after rising to their highest in two weeks, as renewed concerns about the spread of Ebola weighed on market sentiment.The FTSE 100 was down 0.6% at 6,380 in early deals, after having closed Thursday's session at 6,419.15, its highest finish since 9 October.A New York-based doctor who has recently been working in Guinea has become the fourth person in the US to have been diagnosed with Ebola. Craig Spencer reportedly came down with a fever on Thursday and has now been transferred to a hospital in Manhattan.US stock futures were trading lower on Friday after a strong surge the previous day after earnings results from the likes Caterpillar, 3M and General Motors impressed the market, along with decent economic data. After the closing bell, Microsoft's shares jumped after sales and profits beat forecasts, but Amazon.com reported a worse-than-expected quarterly loss.In other news, markets were also digesting the news that Chinese property prices fell at an annual rate of 1.3% in September, the first year-on-year decline in nearly two years. The data "will no doubt intensify calls for more stimulus to avoid a bubble bust and hard landing", said Mike van Dulken, head of research at Accendo Markets.This side of the Pond, investors will be on the lookout for the preliminary estimate of third-quarter UK gross domestic product (GDP) growth, due out at 09:30. GDP growth is expected to have slowed to an annual rate of 0.7% in the July-September period, from 0.9% growth in the second quarter, according to consensus forecasts.Ebola worries hit travel stocksAirlines, travel and leisure stocks were in the red on the back of Ebola fears, with IAG, Easyjet, Intercontinental Hotels, TUI Travel, Carnival and Thomas Cook all registering losses.Publishing and education group Pearson fell after revealing that its chief financial officer is to step down after 10 years of service. The Financial Times owner reiterated its profit guidance for the full year, but shares were under pressure early on.Later on in the session, third-quarter numbers from pharmaceutical group Shire will no doubt be closely watched following the recent failed $54bn takeover by US rival Abbvie. The stock was lower in morning trade.UK challenger bank TSB reported 32% higher third-quarter profits and said it was ahead of its long-term target in attracting customers switching from other banks, helping shares higher early on.Pet shop chain Pets at Home was also in demand after saying first-half sales increased and it was on track to hit full-year forecasts. Total revenue rose 10.2% to £381.5m in the 28 week period ended 9 October.Molten metal flow engineering firm Vesuvius disappointed investors with a gloomy outlook, saying it has seen a "softening in market conditions in certain regions" since the half-year stage.Pharmaceuticals group Hikma dropped after revealed it had received a warning letter from the US Food and Drug Administration relating to its manufacturing facility in Portugal. The agency raised issues related to investigations and environmental monitoring at the facility. Market MoverstechMARK 2,677.15 -0.46%FTSE 100 6,380.41 -0.60%FTSE 250 15,087.41 -0.32%FTSE 100 - RisersCRH (CRH) 1,387.00p +0.73%British Sky Broadcasting Group (BSY) 865.50p +0.70%Vodafone Group (VOD) 198.05p +0.61%Sports Direct International (SPD) 633.00p +0.48%Meggitt (MGGT) 446.10p +0.47%Randgold Resources Ltd. (RRS) 4,101.00p +0.47%ITV (ITV) 200.30p +0.45%Lloyds Banking Group (LLOY) 76.64p +0.41%Prudential (PRU) 1,374.50p +0.26%Dixons Carphone (DC.) 379.80p +0.21%FTSE 100 - FallersTesco (TSCO) 166.00p -2.92%BT Group (BT.A) 366.00p -2.81%InterContinental Hotels Group (IHG) 2,200.00p -2.65%Anglo American (AAL) 1,317.00p -1.72%Associated British Foods (ABF) 2,693.00p -1.68%AstraZeneca (AZN) 4,262.00p -1.67%Pearson (PSON) 1,152.00p -1.45%Aggreko (AGK) 1,534.00p -1.35%Sainsbury (J) (SBRY) 234.00p -1.35%BP (BP.) 433.25p -1.30%FTSE 250 - RisersSpectris (SXS) 1,706.00p +3.71%Pets at Home Group (PETS) 177.70p +3.31%Just Retirement Group (JRG) 130.90p +2.43%Morgan Advanced Materials (MGAM) 294.10p +2.12%Spire Healthcare Group (SPI) 274.00p +1.78%Diploma (DPLM) 685.00p +1.71%African Barrick Gold (ABG) 203.20p +1.60%Domino Printing Sciences (DNO) 588.50p +1.47%Essentra (ESNT) 669.50p +1.44%SSP Group (SSPG) 235.80p +1.20%FTSE 250 - FallersHikma Pharmaceuticals (HIK) 1,815.00p -4.47%Brit (BRIT) 229.30p -3.82%TalkTalk Telecom Group (TALK) 282.60p -3.05%Debenhams (DEB) 61.50p -3.00%Foxtons Group (FOXT) 160.70p -2.61%Euromoney Institutional Investor (ERM) 1,011.00p -2.13%Fidessa Group (FDSA) 2,244.00p -2.09%Cranswick (CWK) 1,284.00p -1.61%Domino's Pizza Group (DOM) 592.50p -1.50%Bank of Georgia Holdings (BGEO) 2,492.00p -1.50%
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.